{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Nutraceuticals", "Observational study", "Pediatric migraine", "Prophylaxis", "Tanacetum parthenium"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30871574", "DateCompleted": {"Year": "2019", "Month": "08", "Day": "06"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "03", "Day": "12"}], "Language": ["eng"], "ELocationID": ["36", "10.1186/s13052-019-0624-z"], "Journal": {"ISSN": "1824-7288", "JournalIssue": {"Volume": "45", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Mar", "Day": "12"}}, "Title": "Italian journal of pediatrics", "ISOAbbreviation": "Ital J Pediatr"}, "ArticleTitle": "An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.", "Pagination": {"StartPage": "36", "MedlinePgn": "36"}, "Abstract": {"AbstractText": ["Migraine is one of the most prevalent chronic pain manifestations of childhood. Despite the multitude of available treatments, parents are often concerned about chronic therapies and pediatricians have insufficient confidence in prescribing prophylactic drugs. Therefore, there is now growing interest for natural supplements used to control recurrent migraine headaches. Such approach may increase acceptance and adherence to long-term prophylaxis therapy in children.", "This is an observational multicenter study performed in children (n\u2009=\u200991) with migraine, with (MO) or without aura (MA), or tension-type headache (TTH). A fixed-dose Andrographis paniculata, CoQ10, riboflavin, and magnesium, was administered for 16\u2009weeks. Patients were evaluated at baseline (T0), at week 8 (T1) and at the end of treatment at week 16 (T2). A follow-up period occurred at week 20 (T3) and week 32 (T4).", "The herbal supplement significantly reduced the frequency of headaches in TTH patients during treatment period (T0: 11.97\u00a0+\u00a01.92 vs T2: 5.13\u00a0+\u00a01.93; p\u2009<\u20090.001) and the efficacy was maintained after 16\u2009weeks of treatment withdrawal (T4: 4.46\u00a0+\u00a01.75; p\u2009<\u20090.001 vs T0). The frequency of migraine attacks was also reduced in the MO group during treatment (T0: 9.70\u00a0+\u00a00.96 vs T2: 4.03\u00a0+\u00a00.75; p\u2009<\u20090.01) and after withdrawal (T4: 2.96\u00a0+\u00a00.65; p\u2009<\u20090.01 vs T0). Conversely, MA patients showed reduction in migraine's frequency during treatment (T0: 8.74\u00a0+\u00a01.91 vs T2: 3.78\u00a0+\u00a02.02; p\u2009<\u20090.01) but not at the end of the study (T4: 5.57\u00a0+\u00a03.31; p\u2009>\u20090.05 vs T0). TTH patients did not report significant improvement of pain intensity. A significant effect was observed in the MO group during treatment (T0: 3.06\u00a0+\u00a00.11 vs T2: 2.14\u00a0+\u00a00.19; p\u2009<\u20090.001) and after treatment withdrawal (T4: 2.20\u00a0+\u00a00.21; p\u2009<\u20090.001 vs T0). Likewise, MA group showed a significant treatment effect (T0: 2.57\u00a0+\u00a00.20 vs T2: 0.86\u00a0+\u00a00.45; p\u2009<\u20090.001) and the efficacy persisted at the end of the study (T4: 1.00\u00a0+\u00a00.58; p\u2009<\u20090.001 vs T0).", "This fixed-dose Tanacetum parthenium preparation improved headache frequency and pain intensity in children affected by TTH. Despite the main limits, this study supports the use of nutraceutical in pediatric headache/migraine."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Child & Adolescent Neuropsychiatry, Hospital S. Orsola Malpighi, Bologna University, Bologna, Italy."}], "LastName": "Moscano", "ForeName": "Filomena", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Child Neurology, Pediatric Headache & Sleep Disorders Centre, Chair of Pediatrics, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University, Via Di Grottarossa, 1035-1039, 00189, Rome, Italy."}], "LastName": "Guiducci", "ForeName": "Michela", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Child & Adolescent Neuropsychiatry, Hospital S. Orsola Malpighi, Bologna University, Bologna, Italy."}], "LastName": "Maltoni", "ForeName": "Lucia", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Paediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 'G. Gaslini' Institute, Genoa, Italy."}], "LastName": "Striano", "ForeName": "Pasquale", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Child & Adolescent Neuropsychiatry Unit, \"Antonio Cao\" Paediatric Hospital, \"G.Brotzu\" Hospital, Cagliari, Italy."}], "LastName": "Ledda", "ForeName": "Maria Giuseppina", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Headache Center, Neurology Unit Hospital, University of Sassari, Sassari, Italy."}], "LastName": "Zoroddu", "ForeName": "Francesco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Emergency Department, Bambino Ges\u00f9 Children's Hospital, IRCCS, Rome, Italy."}], "LastName": "Raucci", "ForeName": "Umberto", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Child Neurology, Pediatric Headache & Sleep Disorders Centre, Chair of Pediatrics, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University, Via Di Grottarossa, 1035-1039, 00189, Rome, Italy."}], "LastName": "Villa", "ForeName": "Maria Pia", "Initials": "MP"}, {"Identifier": ["0000-0001-9042-8120"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Child Neurology, Pediatric Headache & Sleep Disorders Centre, Chair of Pediatrics, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University, Via Di Grottarossa, 1035-1039, 00189, Rome, Italy. pasquale.parisi@uniroma1.it."}], "LastName": "Parisi", "ForeName": "Pasquale", "Initials": "P"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Multicenter Study", "Observational Study"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Ital J Pediatr", "NlmUniqueID": "101510759", "ISSNLinking": "1720-8424"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "1339-63-5", "NameOfSubstance": "Ubiquinone"}, {"RegistryNumber": "EJ27X76M46", "NameOfSubstance": "coenzyme Q10"}, {"RegistryNumber": "I38ZP9992A", "NameOfSubstance": "Magnesium"}, {"RegistryNumber": "TLM2976OFR", "NameOfSubstance": "Riboflavin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Analysis of Variance"}, {"QualifierName": [], "DescriptorName": "Child"}, {"QualifierName": [], "DescriptorName": "Cohort Studies"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": [], "DescriptorName": "Holistic Health"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Italy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Magnesium"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Migraine Disorders"}, {"QualifierName": [], "DescriptorName": "Pain Measurement"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Riboflavin"}, {"QualifierName": [], "DescriptorName": "Risk Assessment"}, {"QualifierName": [], "DescriptorName": "Severity of Illness Index"}, {"QualifierName": [], "DescriptorName": "Statistics, Nonparametric"}, {"QualifierName": [], "DescriptorName": "Tanacetum parthenium"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Tension-Type Headache"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Ubiquinone"}], "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: All the Authors gave the consent for publication. COMPETING INTERESTS: The authors declare that they have no competing interests. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. No honorarium, grant, or other form of payment was given to anyone to produce the manuscript. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kacperski J, Bazarsky A. New developments in the prophylactic drug treatment of pediatric migraine: what is new in 2017 and where does it leave us? Curr Pain Headache Rep. 2017;21(8):38. doi: 10.1007/s11916-017-0638-4.", "ArticleIdList": ["10.1007/s11916-017-0638-4", "28779443"]}, {"Citation": "Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in paediatric migraine: Characterization of age-related effects using Peds QL 4.0. Cephalalgia. 2004;24:120\u2013127. doi: 10.1111/j.1468-2982.2004.00652.x.", "ArticleIdList": ["10.1111/j.1468-2982.2004.00652.x", "14728707"]}, {"Citation": "Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211. doi: 10.1177/0333102417738202.", "ArticleIdList": ["10.1177/0333102417738202", "29368949"]}, {"Citation": "Termine C, Ozge A, Antonacci F, Natriashvili S, Guidetti V, Wober-Bingol C. Overview of diagnosis and management of pediatric headache. Part II: therapeutic management. J Headache Pain. 2011;12:25\u201334. doi: 10.1007/s10194-010-0256-6.", "ArticleIdList": ["10.1007/s10194-010-0256-6", "PMC3072476", "21170567"]}, {"Citation": "Guidetti V, Galli F. Evolution of headache in childhood and adolescents: an 8-year follow up. Cephalalgia. 1998;18:449\u2013454. doi: 10.1046/j.1468-2982.1998.1807449.x.", "ArticleIdList": ["10.1046/j.1468-2982.1998.1807449.x", "9793696"]}, {"Citation": "Orr SL, Kabbouche MA, O'Brien HL, et al. Paediatric migraine: evidence-based management and future directions. Nat Rev Neurol. 2018;14(9):515\u2013527. doi: 10.1038/s41582-018-0042-7.", "ArticleIdList": ["10.1038/s41582-018-0042-7", "30038237"]}, {"Citation": "El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. A comparative effectiveness meta-analysis of drugs for the prophylaxis of pediatric migraine headache. JAMA Pediatr. 2013;167(3):250\u2013258. doi: 10.1001/jamapediatrics.2013.508.", "ArticleIdList": ["10.1001/jamapediatrics.2013.508", "PMC4692044", "23358935"]}, {"Citation": "Kacperski J, Kabbouche MA, O\u2019Brien HL, Weberding JL. The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord. 2016;9(1):53\u201368. doi: 10.1177/1756285615616586.", "ArticleIdList": ["10.1177/1756285615616586", "PMC4710107", "26788131"]}, {"Citation": "Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and place- Bo for pediatric migraine. N Engl J Med. 2017;376(2):115\u2013124. doi: 10.1056/NEJMoa1610384.", "ArticleIdList": ["10.1056/NEJMoa1610384", "PMC5226887", "27788026"]}, {"Citation": "Evers S, Marziniak M, Frese A, Gralow I. Placebo efficacy in childhood and adolescence migraine: an analysis of double blind and placebo-controlled studies. Cephalalgia. 2009;29:436\u2013444. doi: 10.1111/j.1468-2982.2008.01752.x.", "ArticleIdList": ["10.1111/j.1468-2982.2008.01752.x", "19170687"]}, {"Citation": "Sangermani R, Boncimino A. The use of nutraceutics in children's and adolescent's headache. Neurol Sci. 2017;38(Suppl 1):121\u2013124. doi: 10.1007/s10072-017-2896-7.", "ArticleIdList": ["10.1007/s10072-017-2896-7", "28527085"]}, {"Citation": "Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. 2013;33:629\u2013808. doi: 10.1177/0333102413485658.", "ArticleIdList": ["10.1177/0333102413485658", "23771276"]}, {"Citation": "Grinnon ST, Miller K, Marler JR, Lu Y, Stout A, Odenkirchen J, Kunitz S. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods. Clin Trials. 2012;9(3):322\u2013329. doi: 10.1177/1740774512438980.", "ArticleIdList": ["10.1177/1740774512438980", "PMC3513359", "22371630"]}, {"Citation": "Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the quality standards Subcommittee of the American Academy of neurology and the American headache society. Neurology. 2012;78(17):1346\u20131353. doi: 10.1212/WNL.0b013e3182535d0c.", "ArticleIdList": ["10.1212/WNL.0b013e3182535d0c", "PMC3335449", "22529203"]}, {"Citation": "Greco R, Siani F, Demartini C, et al. Andrographis paniculata shows anti-nociceptive effects in an animal model of sensory hypersensitivity associated with migraine. Functional Neurology. 2016;31(1):53\u201360. doi: 10.11138/FNeur/2016.31.1.053.", "ArticleIdList": ["10.11138/FNeur/2016.31.1.053", "PMC4819820", "27027895"]}, {"Citation": "Societ\u00e0 Italiana per lo Studio delle Cefalee. Linee Guida per la diagnosi e la terapia delle cefalee primarie 2011."}, {"Citation": "Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2015, Issue 4. Art. No.: CD002286. DOI: 10.1002/14651858.CD002286.pub3.", "ArticleIdList": ["PMC7133498", "25892430"]}, {"Citation": "Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 2001;8(8):759\u2013766. PubMed PMID: 11514225", "ArticleIdList": ["11514225"]}, {"Citation": "Tassorelli C, Greco R, Morazzoni P, Riva A, Sandrini G, Nappi G. Parthenolide is the component of Tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine. Cephalalgia: An International Journal of Headache. 2005;25:612\u2013621. doi: 10.1111/j.1468-2982.2005.00915.x.", "ArticleIdList": ["10.1111/j.1468-2982.2005.00915.x", "16033387"]}, {"Citation": "Materazzi S, Benemei S, Fusi C, et al. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting TRPA1 channel. Pain. 2013;154(12):10. doi: 10.1016/j.pain.2013.08.002.", "ArticleIdList": ["10.1016/j.pain.2013.08.002", "PMC3843982", "23933184"]}, {"Citation": "Daniel O, Mauskop A. Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol. 2016;18(4):14. doi: 10.1007/s11940-016-0398-1.", "ArticleIdList": ["10.1007/s11940-016-0398-1", "26923604"]}, {"Citation": "Taylor FR. Nutraceuticals and headache: the biological basis. Headache. 2011;51(3):484\u2013501. doi: 10.1111/j.1526-4610.2011.01847.x.", "ArticleIdList": ["10.1111/j.1526-4610.2011.01847.x", "21352223"]}, {"Citation": "Cevoli S, Favoni V, Cortelli P. Energy metabolism impairment in migraine. Curr Med Chem. 2018. 10.2174/0929867325666180622154411 [Epub ahead of print].", "ArticleIdList": ["29932030"]}, {"Citation": "Markley HG. CoEnzyme Q10 and riboflavin: the mitochondrial connection. Headache. 2012;52(Suppl 2):81\u201387. doi: 10.1111/j.1526-4610.2012.02233.x.", "ArticleIdList": ["10.1111/j.1526-4610.2012.02233.x", "23030537"]}, {"Citation": "S\u00e1ndor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713\u2013715. doi: 10.1212/01.WNL.0000151975.03598.ED.", "ArticleIdList": ["10.1212/01.WNL.0000151975.03598.ED", "15728298"]}, {"Citation": "Orr SL. The evidence for the role of nutraceuticals in the Management of Pediatric Migraine: a review. Curr Pain Headache Rep. 2018;22(5):37. doi: 10.1007/s11916-018-0692-6.", "ArticleIdList": ["10.1007/s11916-018-0692-6", "29619575"]}, {"Citation": "Miles MV, Morrison JA, Horn PS, Tang PH, Pesce AJ. Coenzyme Q10 changes are associated with metabolic syndrome. Clin Chim Acta. 2004;344(1\u20132):173\u2013179. doi: 10.1016/j.cccn.2004.02.016.", "ArticleIdList": ["10.1016/j.cccn.2004.02.016", "15149886"]}, {"Citation": "Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9(3):369\u2013379. doi: 10.1586/14737175.9.3.369.", "ArticleIdList": ["10.1586/14737175.9.3.369", "19271946"]}, {"Citation": "Akbar S. Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. 2011;16(1):66\u201377.", "ArticleIdList": ["21438648"]}, {"Citation": "Blume HK. Childhood headache: a brief review. Pediatr Ann. 2017;46(4):e155\u2013e165. doi: 10.3928/19382359-20170321-02.", "ArticleIdList": ["10.3928/19382359-20170321-02", "28414397"]}, {"Citation": "Hershey AD, Powers SW, Coffey CS, et al. Childhood and adolescent migraine prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, Topiramate and placebo in the prevention of childhood and adolescent migraine. Headache. 2013;53(5):799\u2013816. doi: 10.1111/head.12105.", "ArticleIdList": ["10.1111/head.12105", "PMC3637406", "23594025"]}]}], "History": [{"Year": "2019", "Month": "1", "Day": "8"}, {"Year": "2019", "Month": "2", "Day": "25"}, {"Year": "2019", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["30871574", "PMC6419324", "10.1186/s13052-019-0624-z", "10.1186/s13052-019-0624-z"]}}]}